logo-loader
THC Global Group Ltd

THC Global Group launches SPP ahead of final licensing

Shareholders can acquire shares at 50 cents, being a discount to the last price of 56.5 cents.

three hands dropping coins in jars
The SPP is a capital raising that rewards shareholders’ loyalty

THC Global Group Ltd (ASX:THC) has launched a share purchase plan (SPP) allowing shareholders to apply for up to $15,000 worth of shares priced at 50 cents.

The SPP opens tomorrow and will close on 26 April 2019.

The company sees the offer as an opportunity for shareholders to purchase discounted shares prior to the expected receipt of final licencing.

THC’s chairman Steven Xu said: “With this share purchase plan we are offering our loyal shareholders the opportunity to purchase shares at a discount to the current market price, in advance of the expected final licencing required to transition into full-scale medicinal cannabis production.”

READ: THC Global Group expands into Asia with partnership

Last Friday, THC secured a mutually exclusive partnership with Malaysian agri-tech company Heleogenics Sdn Bhd.

The deal represents a significant first step in the company’s Asian markets strategy.

Quick facts: THC Global Group Ltd

Price: $0.45

Market: ASX
Market Cap: $60.4 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global obtains manufacturing licence for Southport cannabis facility

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris talks to Proactive Investors about receiving a medicinal cannabis manufacturing licence at its large Southport manufacturing facility on Queensland's Gold Coast. The licence is required for the commercial production...

on 9/7/19

2 min read